In last trading session, 2seventy bio Inc (NASDAQ:TSVT) saw 0.37 million shares changing hands with its beta currently measuring 1.74. Company’s recent per share price level of $2.66 trading at $0.04 or 1.53% at ring of the bell on the day assigns it a market valuation of $137.22M. That closing price of TSVT’s stock is at a discount of -140.6% from its 52-week high price of $6.40 and is indicating a premium of 11.65% from its 52-week low price of $2.35. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.21 million shares which gives us an average trading volume of 341.27K if we extend that period to 3-months.
For 2seventy bio Inc (TSVT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.60. Splitting up the data highlights that, out of 7 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
2seventy bio Inc (NASDAQ:TSVT) trade information
Upright in the green during last session for gaining 1.53%, in the last five days TSVT remained trading in the green while hitting it’s week-highest on Friday, 01/31/25 when the stock touched $2.66 price level, adding 6.01% to its value on the day. 2seventy bio Inc’s shares saw a change of -9.52% in year-to-date performance and have moved 2.31% in past 5-day. 2seventy bio Inc (NASDAQ:TSVT) showed a performance of -7.96% in past 30-days. Number of shares sold short was 5.08 million shares which calculate 11.5 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 2 to the stock, which implies a fall of -33.0% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 2. It follows that stock’s current price would jump 24.81% in reaching the projected high whereas dropping to the targeted low would mean a gain of 24.81% for stock’s current value.
2seventy bio Inc (TSVT) estimates and forecasts
Statistics highlight that 2seventy bio Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -43.64% of value to its shares in past 6 months, showing an annual growth rate of 78.96% while that of industry is 16.00. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
2seventy bio Inc (NASDAQ:TSVT)’s Major holders
Insiders are in possession of 4.24% of company’s total shares while institution are holding 90.52 percent of that, with stock having share float percentage of 94.53%. Investors also watch the number of corporate investors in a company very closely, which is 90.52% institutions for 2seventy bio Inc that are currently holding shares of the company. KYNAM CAPITAL MANAGEMENT, LP is the top institutional holder at TSVT for having 5.95 million shares of worth $22.92 million. And as of 2024-06-30, it was holding 11.4341 of the company’s outstanding shares.
The second largest institutional holder is GOLDMAN SACHS GROUP INC, which was holding about 4.14 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.9465 of outstanding shares, having a total worth of $15.93 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 1.54 shares of worth $4.1 million or 2.99% of the total outstanding shares. The later fund manager was in possession of 1.4 shares on Nov 30, 2024 , making its stake of worth around $3.73 million in the company or a holder of 2.72% of company’s stock.
